Full text

Turn on search term navigation

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Functional cosmetics industries using skin microbiome screening and beneficial materials isolated from key microorganisms are receiving increasing attention. Since Epidermidibacterium keratini EPI-7T was first discovered in human skin, previous studies have confirmed that it can produce a new pyrimidine compound, 1,1′-biuracil, having anti-aging effects on human skin. Therefore, we conducted genomic analyses to judge the use value of E. keratini EPI-7T and provide up-to-date information. Whole-genome sequencing analysis of E. keratini EPI-7T was performed to generate new complete genome and annotation information. E. keratini EPI-7T genome was subjected to comparative genomic analysis with a group of closely-related strains and skin flora strains through bioinformatic analysis. Furthermore, based on annotation information, we explored metabolic pathways for valuable substances that can be used in functional cosmetics. In this study, the whole-genome sequencing (WGS) and annotation results of E. keratini EPI-7T were improved, and through comparative analysis, it was confirmed that the E. keratini EPI-7T has more metabolite-related genes than comparison strains. In addition, we annotated the vital genes for biosynthesis of 20 amino acids, orotic acid, riboflavin (B2) and chorismate. In particular, we were able to prospect that orotic acid could accumulate inside E. keratini EPI-7T under uracil-enriched conditions. Therefore, through a genomics approach, this study aims to provide genetic information for the hidden potential of E. keratini EPI-7T and the strain development and biotechnology utilization to be conducted in further studies.

Details

Title
Genome-Wide Pathway Exploration of the Epidermidibacterium keratini EPI-7T
Author
Oh, Yunseok 1   VIAFID ORCID Logo  ; Mun, Seyoung 2   VIAFID ORCID Logo  ; Young-Bong, Choi 3 ; HyungWoo Jo 4 ; Dong-Geol, Lee 4 ; Han, Kyudong 5   VIAFID ORCID Logo 

 Department of Bioconvergence Engineering, Dankook University, Jukjeon, Yongin 16890, Republic of Korea; [email protected]; Department of Microbiology, College of Science & Technology, Dankook University, Cheonan 31116, Republic of Korea; [email protected] (S.M.); [email protected] (H.J.) 
 Department of Microbiology, College of Science & Technology, Dankook University, Cheonan 31116, Republic of Korea; [email protected] (S.M.); [email protected] (H.J.); Center for Bio Medical Engineering Core Facility, Dankook University, Cheonan 31116, Republic of Korea 
 Department of Chemistry, College of Science & Technology, Dankook University, Cheonan 31116, Republic of Korea; [email protected] 
 Department of Microbiology, College of Science & Technology, Dankook University, Cheonan 31116, Republic of Korea; [email protected] (S.M.); [email protected] (H.J.); R&I Center, COSMAX BTI, Pangyo-ro 255, Bundang-gu, Seongnam 13486, Republic of Korea 
 Department of Bioconvergence Engineering, Dankook University, Jukjeon, Yongin 16890, Republic of Korea; [email protected]; Department of Microbiology, College of Science & Technology, Dankook University, Cheonan 31116, Republic of Korea; [email protected] (S.M.); [email protected] (H.J.); Center for Bio Medical Engineering Core Facility, Dankook University, Cheonan 31116, Republic of Korea; R&D Center, HuNBiome Co., Ltd., Gasan Digital 1-ro, Geumcheon-gu, Seoul 08507, Republic of Korea 
First page
870
Publication year
2023
Publication date
2023
Publisher
MDPI AG
e-ISSN
20762607
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2806584314
Copyright
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.